Ontario Clinical Oncology Group (ocog)
Clinical trials sponsored by Ontario Clinical Oncology Group (ocog), explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New dosing strategy aims to keep myeloma patients out of the hospital Results expected Dec 2026 (estimated)
-
One-Week radiation may cut lymphedema risk in breast cancer patients
Disease control OngoingThis study compares a 1-week radiation course to a standard 3-week course for women with node-positive breast cancer. The goal is to see if the shorter treatment is just as effective at preventing cancer from coming back while reducing the risk of lymphedema (arm swelling). About…
Phase 3 • Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Radiation-Free path for Low-Risk breast cancer? new study tests safety
Disease control OngoingThis study is testing whether women over 55 with a specific low-risk type of breast cancer (luminal A) can avoid radiation after lumpectomy. Instead, they take hormone-blocking pills for 5 years. Researchers are tracking 500 women for 10 years to see how many have the cancer come…
Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC